Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects
Clinical trial NCT02750930 · TERMINATED
Trial details
- NCT number
- NCT02750930
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-07
- Primary completion
- 2017-03-21
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.